Effectiveness and safety of mogamulizumab for the treatment of Sézary syndrome in very elderly patients: A real-world, multicentre, retrospective study conducted in France
J Eur Acad Dermatol Venereol
.
2025 Jan;39(1):e84-e86.
doi: 10.1111/jdv.20127.
Epub 2024 May 28.
Authors
E Ribereau-Gayon
1
,
M Beylot-Barry
2
,
A De Masson
3
,
C Ram-Wolff
3
,
M Bagot
3
,
A Pham-Ledard
2
,
F Grange
4
Affiliations
1
Dermatology Department, Hospices Civils de Lyon, Lyon, France.
2
Dermatology Department, CHU Bordeaux, Bordeaux, France.
3
Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.
4
Department of Dermatology, Valence Hospital, Valence, France.
PMID:
38804019
DOI:
10.1111/jdv.20127
No abstract available
Publication types
Letter